Tutorial

This page is intended for folks using HemOnc.org for the first time, although frequent visitors may also learn about new features here. What follows are descriptions of the main features of the wiki.

Table of contents

Almost every page of the wiki has a table of contents, which allows you to jump quickly to the area of the page that you are most interested in. The chemotherapy regimen pages also have a "back to top" button that will bring you back to the table of contents.

Main page

This is the landing page of HemOnc.org and is primarily a portal to get to the regimen pages, which are organized in three groups: 1) solid oncology; 2) malignant hematology; and 3) other hematology. There are also many links that appear on the left-hand side navigation bar, which will in fact appear on any page of the wiki.

Chemotherapy regimen pages

Chemotherapy regimens are grouped into individual pages by cancer histology, or sometimes by related histologies (for example, the sarcoma page has several distinctly different sarcoma histologies). On a particular page, regimens are listed alphabetically and by context; for example the melanoma page has two sections: 1) adjuvant therapy and 2) metastatic or unresectable disease.

Chemotherapy regimens

We try to use a consistent style for each chemotherapy regimen, so that you can find the information that you are looking for quickly and easily. Here are the components you will find:

Acronym

For regimens that are known by their acronym(s), the first thing we do is spell out the acronym. Since these acronyms often contain outdated or brand-names, we include the generic names in parentheses as indicated.

Example: CHOP: Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Oncovin (Vincristine), Prednisone

Variant

The next thing we do is list each variant of a regimen that we have found, numerically. Right now the order is not really meant to mean anything, although that may change in the future. Generally we consider a variant to be significantly different dosing, significantly different numbers of cycles, or substitution (e.g. prednisolone for prednisone).

Level of evidence

Next, we make an assertion as to the level of evidence of the trial reporting the regimen. Is it a randomized study, or a phase II protocol? Is it a retrospective case series? This section is under active evolution to include links to comparator arms and efficacy; see R-CHOP in follicular lymphoma as one example. For much more information, go to the levels of evidence page.

Antineoplastics

Next, we list the antineoplastic drugs in the same order as the regimen acronym, or alphabetically in the absence of an acronym. Each drug is listed in a particular format:

Generic Name (Brand Name) units per unit measure route frequency on days xyz

Generic Name (Brand Name) is always an active link to the drug page. When a primary reference provides details about infusion time, we include them (this is not common).

Supportive medications

Immediately after the antineoplastics, we provide information on supportive medications such as antihistamines, antiemetics, etc. as provided in the original reference. This information is highly variable and sometimes not present in the original reference, in which case it is omitted.

Dose reductions

We occasionally include information on dose reductions, but this has not been a focus of the HemOnc.org project to date. Please consult the original reference if you suspect you are not treating a standard patient (e.g. age > 70 years old, reduced cardiac function, etc.)!

Treatment duration and subsequent disposition

As with the drug information, we try to maintain a very consistent style here:

xx-day or xx-week cycles x yy cycles or xx-day or xx-week course

If a reference reports on a multi-part regimen, we also include a statement linking the parts together. For example, the AIDA 2000 regimen to treat acute promyelocytic leukemia has an induction phase, a consolidation phase, and a maintenance phase. These are all linked together.

References

Finally, we include all of the original references, in chronological order, that we have used to populate the regimen information. These are listed in PubMed style, and include links to the original article (which is usually not free to access) and the PubMed citation. If a contributor has reviewed the original article for accuracy of content, you will see contains verified protocol. If this statement is not present, please be aware that the information present is based on an abstract and may not be wholly accurate or complete. Of course, our standard disclaimer always applies!